Displaying drugs 1901 - 1925 of 2774 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Oxetacaine | 467.654 C28H41N3O3 |  | An antacid used to treat gastritis, peptic ulcer disease, heartburn, esophagitis, hiatus hernia, and anorexia. | Anesthetics, Local |
| Ambenonium | 537.565 C28H42Cl2N4O2 |  | A cholinesterase inhibitor that targets both muscarinic and nicotinic receptors indicated for the treatment of myasthenia gravis. | Parasympathomimetics |
| Hyaluronic acid | 776.6486 C28H44N2O23 |  | A glycosaminoglycan used for the relief of joint pain, wound healing, ophthalmologic treatment, cosmetic treatment, and various other applications. | Viscoelastic Substances |
| Ergocalciferol | 396.6484 C28H44O |  | A vitamin found in many supplement products. | Vitamins |
| Ergosterol | 396.659 C28H44O |  | A steroid of interest both because its biosynthesis in FUNGI is a target of ANTIFUNGAL AGENTS, notably AZOLES, and because when it is present in SKIN of animals, ULTRAVIOLET RAYS... | Cholestenes / Provitamins |
| Doxercalciferol | 412.6478 C28H44O2 |  | A synthetic vitamin D2 analog used to treat secondary hyperparathyroidism in patients with chronic kidney disease with or without therapy of dialysis. | Bone Density Conservation Agents / Vitamin D and Analogues / Vitamins |
| Nandrolone decanoate | 428.6472 C28H44O3 |  | An anabolic steroid indicated for the management of the anemia of renal insufficiency by increasing hemoglobin and red cell mass. | Anabolic Agents / Androgens / Bone Density Conservation Agents / Nandrolone and esters |
| Lefamulin | 507.73 C28H45NO5S |  | A pleuromutilin antibacterial used to treat community-acquired bacterial pneumonia (CABP). | Anti-Bacterial Agents |
| Benzylpenicilloyl polylysine | 626.765 C28H46N6O8S |  | A penicillin derivative used to determine penicillin allergies. | Acetamides / Amides / Anti-Bacterial Agents / Antibacterials for Systemic Use / Antiinfectives for Systemic Use / Benzene Derivatives / beta-Lactams / Drug Hypersensitivity / Heterocyclic Compounds, Fused-Ring / Lactams / Penicillins / Sulfur Compounds |
| Dihydrotachysterol | 398.6642 C28H46O |  | A synthetic analog of vitamin D that does not require renal activation like vitamin D2 or Vitamin D3. | Vitamin D and Analogues |
| Plerixafor | 502.782 C28H54N8 |  | A CXCR4 antagonist used in combination with granulocyte-colony stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and autologous transplantation in patients with non-Hodgkin’s lymphoma and multiple myeloma. | Anti-HIV Agents / Hematopoietic Stem Cell Mobilizer |
| Atogepant | 603.525 C29H23F6N5O3 |  | An oral CGRP antagonist used for the preventative therapy of episodic migraine headaches. | Calcitonin Gene-Related Peptide Receptor Antagonists |
| Lifitegrast | 615.48 C29H24Cl2N2O7S |  | A medication used to treat dry eye disease. | Lymphocyte Function-Associated Antigen-1 / Lymphocyte Function-Associated Antigen-1 Antagonist / Ophthalmic Solutions |
| Lapatinib | 581.058 C29H26ClFN4O4S |  | An antineoplastic agent and tyrosine kinase inhibitor used for the treatment of advanced or metastatic HER-positive breast cancer in patients who received prior chemotherapeutic treatments. | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
| Ubrogepant | 549.554 C29H26F3N5O3 |  | An oral CGRP antagonist used in the acute treatment of migraine with or without aura. | Calcitonin Gene-Related Peptide (CGRP) Antagonists |
| Relugolix | 623.64 C29H27F2N7O5S |  | An oral GnRH receptor antagonist for androgen deprivation therapy in the treatment of advanced prostate cancer. | Anti-Gonadotropin-Releasing Hormones |
| Ponatinib | 532.5595 C29H27F3N6O |  | A kinase inhibitor used to treat patients with various types of chronic myeloid leukemia (CML). | Bcr-Abl Tyrosine Kinase Inhibitors / Protein Kinase Inhibitors |
| Letermovir | 572.561 C29H28F4N4O4 |  | An antiviral medication used for prophylaxis in adult transplant recipients at risk of cytomegalovirus (CMV) infection and disease. | Antiviral Agents / Cytomegalovirus DNA Terminase Complex Inhibitor / Poly(ADP-ribose) Polymerase Inhibitors |
| Tepotinib | 492.583 C29H28N6O2 |  | An oral tyrosine kinase inhibitor targeted against MET for the treatment of metastatic non-small cell lung cancer in patients exhibiting MET exon 14 skipping mutations. | Antineoplastic Agents / Kinase Inhibitor / Proto-Oncogene Proteins c-met, antagonists & inhibitors |
| Fluspirilene | 475.5727 C29H31F2N3O |  | An antipsychotic agent used in the treatment of schizophrenia. | Diphenylbutylpiperidine Derivatives |
| Imatinib | 493.6027 C29H31N7O |  | A tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors. | Bcr-Abl Tyrosine Kinase Inhibitors / Protein Kinase Inhibitors |
| Selpercatinib | 525.613 C29H31N7O3 |  | A RET receptor tyrosine kinase inhibitor for the treatment of RET-driven non-small cell lung cancer, medullary thyroid cancer, and thyroid cancer in appropriate patient populations. | Kinase Inhibitor |
| Lusutrombopag | 591.54 C29H32Cl2N2O5S |  | A medication used to treat thrombocytopenia in patients with chronic liver disease scheduled to have a procedure. | Acids, Carbocyclic / BCRP/ABCG2 Substrates / Blood and Blood Forming Organs / Hemostatics / P-glycoprotein substrates / Sulfur Compounds / Thrombopoietin Receptor Agonist |
| Piperaquine | 535.52 C29H32Cl2N6 |  | For the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg [FDA Label]. Used in combination with DB11638. | Anti-Infective Agents / Antimalarials / Antiparasitic Agents / Antiparasitic Products, Insecticides and Repellents / Antiprotozoals / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (weak) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP2E1 Inducers / Cytochrome P-450 CYP2E1 Inducers (strength unknown) / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Heterocyclic Compounds, Fused-Ring |
| Quizartinib | 560.67 C29H32N6O4S |  | A FLT3 inhibitor used in combination with cytarabine and anthracycline to treat acute myeloid leukemia with FLT3 internal tandem duplication | Protein Kinase Inhibitors / Tyrosine Kinase Inhibitors |
Displaying drugs 1901 - 1925 of 2774 in total